Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Participants With Persistent Asthma

Study Title
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
Teva Identifier
FSS-AS-30017 | 2014-000923-25
ClinicalTrials.gov Identifier
NCT02141854
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: FS MDPI | Drug: Fp MDPI | Drug: Placebo MDPI | Drug: Albuterol/salmeterol HFA MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
06/01/2014 - 09/01/2015
Phase
Phase 3

Study Type

Interventional